By Laura Otto via UWM Report The UWM Research Foundation has recently awarded Catalyst Grant funding totaling $150,000 for UWM research projects that focus on new treatments for human health. Now in its 15th year, the Catalyst Grant Program collectively has awarded more than $5.58 million dollars...
By Laura Otto via UWM Report The UWM Research Foundation has awarded a total of $178,220 to five UWM startups that are managed by faculty, students or staff and also have licensed intellectual property from the Research Foundation. These Bridge Grants are designed to provide “gap” funding...
A few highlights from the article in MKE Startup News about UWM's researcher and co-founder of Estrigenix Therapeutics, Karyn Frick: About Dr. Frick Frick is a renowned neuroscientist who wears many hats. Beyond teaching, running a federally-funded research lab and co-directing the university’s new Neuroscience major, she...
RespireRx Pharmaceuticals Inc. is a leader in the discovery and development of medicines for the treatment of psychiatric and neurological disorders, with a focus on treatment options that address conditions affecting millions of people, but for which there are few or poor treatment options, including...
Backstory Dr. Yi Hu’s passion for helping those who are hearing impaired is a personal one. “About 16 years ago, my grandpa started complaining about his hearing loss and tinnitus* conditions. I guess it was from that time I started to grow a passion to develop...
RoddyMedical, Inc. announced the closing of its $600,000 series seed investment round and partnership with the Winnebago Seed Fund, and the Winnow Fund, two of Wisconsin’s Badger Fund of Fund venture capital firms. The seed round will finance the manufacturing and product launch of the...
The UWM Research Foundation recently completed awarding Catalyst Grants to three projects. Now in its fourteenth year, the Catalyst Grant Program has awarded over $5.5 million dollars in seed funding for 101 projects. These projects have led to 55 issued patents, 31 license/option agreements, and more...
